In a significant milestone for the pharmaceutical industry, Corpol is proud to announce the Certification of Good Practices in Pharmacovigilance granted by the General Directorate of Medicines, Supplies and Drugs (Digemid) to OQCorp S.A.C. This certification reflects the company’s continued commitment to safety and effectiveness of its products, as well as its dedication to ensuring the health and well-being of patients.
The Certification of Good Practices in Pharmacovigilance is a fundamental recognition that validates the rigorous standards and the processes implemented by Corpol in monitoring, evaluation and safety management of its pharmaceutical products. This achievement demonstrates the fulfillment of the company with the regulations and guidelines established by the regulatory authority, guaranteeing that the highest standards are followed in the field of pharmacovigilance.
Pharmacovigilance plays a crucial role in the pharmaceutical industry by identifying, evaluate and prevent the risks associated with the use of medications. Obtaining this certification underscores Corpol’s commitment to maintaining constant oversight of the safety of its products throughout their life cycle.
This achievement reflects the hard work and dedication of the Corpol team in monitoring our products. Corpol remains committed to excellence in all its operations, facilitating access to high quality products.
